arrow
K

Klemens Budde

Charité - Universitätsmedizin Berlin
H指数:89
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world utilization patterns and association of dd-cfDNA with biopsy and rejection

真实世界dd-cfDNA利用模式及其与活检和排斥反应的关联

2026-07-230
OAAI
A multicenter registry study of the CD38 antibody daratumumab for the treatment of microvascular inflammation following kidney transplantation

CD38抗体达拉木单抗治疗肾移植后微血管炎的多中心注册研究

2026-07-230
OA
Normalization of nCounter Gene Expression Data Alters Molecular Diagnostics in Kidney Transplantation

对nCounter基因表达数据的标准化改变了肾脏移植中的分子诊断

2026-04-010
PRE
RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls

肾移植受者和透析患者与健康对照组的RSVPreF3OA疫苗应答

2026-02-010
PRE
NK cell missing self in microvascular inflammation with and without donor-specific antibodies

NK细胞在微血管炎症中的缺失自我识别,以及有无供者特异性抗体的情况

2026-01-010
PRE
Effect of felzartamab anti-CD38 treatment on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies

Felzartamab抗CD38治疗对肾移植活检中抗体介导排斥反应分子表型的影响

2025-10-010
PRE
Deep phenotyping of urinary cells with cytometry by time of flight reveals CD8+CD38+T cells as biomarker to detect T cell-mediated rejection

利用飞行时间流式细胞术对尿细胞进行深度表型分析,揭示了CD8+CD38+T细胞可作为检测T细胞介导排斥反应的生物标志物。

2025-10-010
OAAI
Improving the histologic detection of DSA-negative antibody-mediated rejection in kidney transplants

提高肾移植中DSA阴性抗体介导排斥反应的病理学检测

2025-08-230
OAAI
Impact of kidney function on 200 days of antiviral prophylaxis for cytomegalovirus disease in CMV-seronegative recipients of CMV-seropositive donor kidneys Post hoc analysis of a randomized, phase 3 trial of letermovir versus valganciclovir prophylaxis

肾功能对CMV-seronegative受者接受CMV-seropositive供肾者肾脏后200天巨细胞病毒疾病抗病毒预防的影响:一项关于letermovir与valganciclovir预防的随机、III期试验的事后分析

2025-07-210
PREAI